266 related articles for article (PubMed ID: 27558072)
1. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.
Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH
Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072
[TBL] [Abstract][Full Text] [Related]
2. PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).
Stinton LM; Bentow C; Mahler M; Norman GL; Eksteen B; Mason AL; Kaplan GG; Lindkvist B; Hirschfield GM; Milkiewicz P; Cheung A; Janssen HL; Fritzler MJ
PLoS One; 2014; 9(11):e112877. PubMed ID: 25397578
[TBL] [Abstract][Full Text] [Related]
3. IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis.
Schwarze C; Terjung B; Lilienweiss P; Beuers U; Herzog V; Sauerbruch T; Spengler U
Clin Exp Immunol; 2003 Aug; 133(2):283-9. PubMed ID: 12869036
[TBL] [Abstract][Full Text] [Related]
4. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.
Bansi DS; Fleming KA; Chapman RW
Gut; 1996 Mar; 38(3):384-9. PubMed ID: 8675091
[TBL] [Abstract][Full Text] [Related]
5. Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.
Naess S; Björnsson E; Anmarkrud JA; Al Mamari S; Juran BD; Lazaridis KN; Chapman R; Bergquist A; Melum E; Marsh SG; Schrumpf E; Lie BA; Boberg KM; Karlsen TH; Hov JR
Liver Int; 2014 Nov; 34(10):1488-95. PubMed ID: 24517468
[TBL] [Abstract][Full Text] [Related]
6. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis.
Lenzen H; Weismüller TJ; Negm AA; Wlecke J; Loges S; Strassburg CP; Manns MP; Lankisch TO
Scand J Gastroenterol; 2013 Oct; 48(10):1205-12. PubMed ID: 23957616
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?
Seibold F; Weber P; Schöning A; Mörk H; Goppel S; Scheurlen M
Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1095-100. PubMed ID: 8944372
[TBL] [Abstract][Full Text] [Related]
8. Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C.
Hov JR; Lleo A; Selmi C; Woldseth B; Fabris L; Strazzabosco M; Karlsen TH; Invernizzi P
J Hepatol; 2010 May; 52(5):712-7. PubMed ID: 20347497
[TBL] [Abstract][Full Text] [Related]
9. Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.
Bansi DS; Bauducci M; Bergqvist A; Boberg K; Broome U; Chapman R; Fleming K; Jorgensen R; Lindor K; Rosina F; Schrumpf E
Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):575-80. PubMed ID: 9222729
[TBL] [Abstract][Full Text] [Related]
10. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
Vidrich A; Lee J; James E; Cobb L; Targan S
J Clin Immunol; 1995 Nov; 15(6):293-9. PubMed ID: 8576315
[TBL] [Abstract][Full Text] [Related]
11. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis.
Dobric S; Popovic D; Nikolic M; Andrejevic S; Spuran M; Bonaci-Nikolic B
Clin Chem Lab Med; 2011 Nov; 50(3):503-9. PubMed ID: 22107137
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
13. Association of HLA-DRB1 alleles and anti-neutrophil cytoplasmic antibodies in Han and Uyghur patients with ulcerative colitis in China.
Gao F; Aheman A; Lu JJ; Abuduhadeer M; Li YX; Kuerbanjiang A
J Dig Dis; 2014 Jun; 15(6):299-305. PubMed ID: 24597629
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
Bansi DS; Chapman RW; Fleming KA
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody profile of primary sclerosing cholangitis.
Gur H; Shen G; Sutjita M; Terrberry J; Alosachie I; Barka N; Lin HC; Peter JB; Meroni PL; Kaplan M
Pathobiology; 1995; 63(2):76-82. PubMed ID: 8554703
[TBL] [Abstract][Full Text] [Related]
17. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
Seibold F; Slametschka D; Gregor M; Weber P
Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
[TBL] [Abstract][Full Text] [Related]
19. Anti-Proteinase 3 Antibodies as a Biomarker for Ulcerative Colitis and Primary Sclerosing Cholangitis in Children.
Laass MW; Ziesmann J; de Laffolie J; Röber N; Conrad K
J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):463-470. PubMed ID: 35703948
[TBL] [Abstract][Full Text] [Related]
20. Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis.
Pokorny CS; Norton ID; McCaughan GW; Selby WS
J Gastroenterol Hepatol; 1994; 9(1):40-4. PubMed ID: 8155865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]